Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ: SNOA · IEX Real-Time Price · USD

0.156

-0.004 (-2.80%)

At close: Apr 26, 2024, 3:58 PM

0.160

+0.004 (2.30%)

After-hours: Apr 26, 2024, 4:00 PM EDT

Sonoma Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2003
Net Income	-5.15	-5.09	-3.95	-3.31	-11.8	-14.33	9.27	-10.16	-8.2	3.74	Upgrade
Depreciation & Amortization	0.13	0.19	0.23	0.31	0.45	0.49	0.25	0.24	0.25	0.28	Upgrade
Share-Based Compensation	0.67	0.38	0.37	0.84	1.64	2.5	2.15	2.15	1.77	1.45	Upgrade
Other Operating Activities	-1.8	0.27	-0.03	-2.43	-2.01	-1.1	-19.83	-0.98	-0.52	-10.36	Upgrade
Operating Cash Flow	-6.15	-4.25	-3.38	-4.59	-11.72	-12.44	-8.17	-8.75	-6.69	-4.89	Upgrade
Capital Expenditures	-0.27	-0.14	-0.18	-0.21	-0.1	-0.19	-0.39	-0.35	-0.14	-0.5	Upgrade
Acquisitions	0	0	0.61	3.8	0	0	18.64	0	0	0	Upgrade
Change in Investments	0.01	0.04	-0.04	0.05	-0.03	-0.01	-0.02	4.54	0.96	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	0.05	0.06	Upgrade
Investing Cash Flow	-0.26	-0.1	0.39	3.64	-0.13	-0.2	18.22	4.19	0.88	-0.45	Upgrade
Share Issuance / Repurchase	2.87	7.77	2.29	1.38	5.7	5.52	0.1	6.16	6.79	4.48	Upgrade
Debt Issued / Paid	-0.38	-0.37	0.83	-0.33	-0.48	-0.28	-0.13	-0.12	-0.18	-1.62	Upgrade
Other Financing Activities	-	-	0.19	-0.01	0.27	-	-	-	-	0.08	Upgrade
Financing Cash Flow	2.49	7.4	3.31	1.03	5.49	5.24	-0.03	6.04	6.61	2.95	Upgrade
Exchange Rate Effect	0.35	0.13	0.21	-0.08	-0.02	0.01	-0.03	-0.15	-0.13	-0.03	Upgrade
Net Cash Flow	-3.58	3.18	0.53	0	-6.38	-7.4	9.99	1.33	0.66	-2.42	Upgrade
Free Cash Flow	-6.42	-4.39	-3.56	-4.8	-11.82	-12.63	-8.56	-9.09	-6.83	-5.39	Upgrade
Free Cash Flow Margin	-48.38%	-34.72%	-19.09%	-26.76%	-62.29%	-75.80%	-66.75%	-97.03%	-49.32%	-39.46%	Upgrade
Free Cash Flow Per Share	-1.89	-1.65	-1.78	-3.25	-12.79	-25.10	-18.24	-24.88	-31.84	-35.27	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).